HTA136 Analysis of the Reimbursement and Pricing of Hybrid Medicines in France von Gaugy, P., Cottin, J.

Volltext

PNS76 Why EARLY Access Price Should be Analyzed with Caution? von Coudray, C., Gaugy, P.

Volltext

HTA149 Early Access Reform in France: Descriptive Analysis of First EAP Decisions von Le Mao, J, Gaugy, P

Volltext

HTA284 Early Access in France: Descriptive Analysis of Eap Decisions Two Years after the Reform von Le Mao, J., Edart, R., Gaugy, P.

Volltext